课题基金 / 基金详情

Development of novel therapeutic strategy against tumor progression using animal model

Development of novel therapeutic strategy against tumor progression using animal model
使用动物模型开发针对肿瘤进展的新治疗策略
批准号:
21590432
负责人:
KITAGAWA Masanobu
金额:
$3.0万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

KITAGAWA Masanobu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The interaction of viral proteins with host-cellular proteins elicits the activation of cellular signal transduction pathways. Previously, we have clarified that an infection with Friend leukemia virus(FLV) markedly enhanced the IR-induced apoptosis of hematopoietic cells in C3H mice in association with P53, ATM, and DNA-PK. The phenomenon was characterized in vivo by severe anemia when the mice were infected with FLV and then treated with a low dose of total body irradiation(TBI). Viral infection and replication occurred almost cell type-specifically in the hematopoietic cells and thus, the apoptotic enhancement was observed only in the hematopoietic cells. However, p53 knockout mice, Atm knockout mice, and DNA-PK-deficient SCID mice with a C3H background did not exhibit this phenotype. A comparison of apoptotic signals after FLV, TBI, or FLV+TBI treatment of these mice revealed that ATM appeared to be necessary for the general signal transduction of TBI-induced apoptosis, while DNA-PK had a specific role in enhancing p53-dependent apoptosis under FLV infection. The host specificity of this phenomenon was caused by the up-regulated expression of Acinus and minichromosome maintenance(MCM) 2 in C3H mice. We also showed that C3H mouse-derived hematopoietic cells originally expressed higher levels of MCM2 than BALB/c cells and exhibited more frequent apoptosis after DNA-damage by doxorubicin when the cells expressed the Friend leukemia virus envelope protein gp70. Transduction and immunoprecipitation assays using various deletion mutants of
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
プレB細胞性リンパ性白血病発症におけるC/ebpβとBLNK/IL-7 シグナルの協調作用について
C/ebpβ 和 BLNK/IL-7 信号在前 B 淋巴细胞白血病发展中的协同作用
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Yuichi Murakami, Kosuke Watari, Tomohiro Shibata, Hiroki Ureshino, Akihiko Kawahara, Masayoshi Kage, Hiroto Izumi, Michihiko Kuwano, Mayumi Ono., 倉田盛人, NiuDongfengら, Ueha S, 倉田盛人, 12. 河原明彦,原田博史,多比良朋希,山口知彦,安部秀幸,吉田友子,髙瀨頼妃呼,福満千容,秋葉 純,鹿毛政義., 望月邦夫ら, 倉田盛人,北川昌伸,後飯塚僚,北村大介,中村卓郎]
通讯作者: 倉田盛人,北川昌伸,後飯塚僚,北村大介,中村卓郎
DNA損傷アポトーシス増強による癌治療動物モデル.
癌症治疗动物模型通过DNA损伤增强细胞凋亡。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [北川昌伸, 倉田盛人, 阿部晋也, 鈴木志保, 梅田茂明, 菅原江美子, 大西威一郎]
通讯作者: 大西威一郎
血液発症におけるERストレス蛋白Xbp-1の機能
ER应激蛋白Xbp-1在血液发病机制中的作用
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [倉田盛人, 北川昌伸, 中村卓郎]
通讯作者: 中村卓郎
Giant cell carcinoma causing rapidly progressive respiratory failure as the presenting feature of acquired immunodeficiency syndrome
巨细胞癌导致快速进行性呼吸衰竭,这是获得性免疫缺陷综合征的表现特征
DOI: --
发表时间: 2010
期刊: Int J STD AIDS
影响因子: 1.4
作者: [Sugawara E, Yamamoto K, Umeda S, Suzuki S, KurataM, Endo Y, Uchibori K, Akashi T, Inase N, Kitagawa M]
通讯作者: Kitagawa M
59
    Development of novel therapeutic strategy against highly malignant tumors
    • 批准号:
      15K08394
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    Development of anti-tumor therapy model using MCM2 function
    • 批准号:
      24590476
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    Enhancement of radiation-induced apoptosis by retroviral infection : implication for the gene therapy
    • 批准号:
      14570180
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2002
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    Establishment of the gene therapy model for protecting retroviral infection
    • 批准号:
      11670206
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      1999
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    海外基金